We demonstrated that mRNA expression of hBD2 (DEFB4A) and LL-37 was significantly increased in TH17 cytokine-induced collagen-based psoriasis models compared with expression in untreated skin constructs, but expression of hBD1 (DEFB1) was not enhanced (Fig. 6A). The gene discussed is CAMP; the disease is psoriasis.